Whole body (WB) MRI is developing as a cancer staging platform in primary prostate cancer, although has not yet been adopted into clinical practice. In this study, we show that WB-MRI provides high levels of interobserver concordance, intermodality concordance and diagnostic accuracy for both nodal and metastatic bone disease, with higher levels of sensitivity than BS for metastatic disease, and similar performance to PET/CT. We also show that T2W and post contrast mDixon have no additive diagnostic value above T1W and DWI alone.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords